Ocular Therapeutix, Inc. Share Price
NASDAQ: OCULHealthcare
Live Ocular Therapeutix, Inc. Share Price Chart
O H L
Ocular Therapeutix, Inc. Performance Overview
Days Range
▼
$10.03Low
$10.15High
Markets Today
| Previous Close | $10.14 |
|---|---|
| Open | $10.09 |
| Volume | 263,062 |
| Day's Range | $10.03 - $10.15 |
| 52W Range | $6.23 - $16.44 |
| Market Cap | $2.17 B |
Historical Performance
| 1M Returns | -7.90 |
|---|---|
| 3M Returns | +7.53 |
| 6M Returns | +19.43 |
| 1Y Returns | -20.22 |
| 5Y Returns | -3.89 |
| 10Y Returns | +51.34 |
Ocular Therapeutix, Inc. Fundamentals
| Market Cap | $2.17 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $51.95 M |
| ROE TTM | -0.55 |
| EPS TTM | $-1.41 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.17 |
| EBITDA | $-265.69 M |
| Profit Margin | -511.90 |
| Market Cap | $2.17 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $51.95 M |
| ROE TTM | -0.55 |
| EPS TTM | $-1.41 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.17 |
| EBITDA | $-265.69 M |
| Profit Margin | -511.90 |
Ocular Therapeutix, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $10.70 M | $13.46 M | $14.54 M | $13.25 M | $10.79 M | $13.47 M |
| Gross Profit + | $9.44 M | $11.52 M | $12.77 M | $11.66 M | $9.46 M | $11.46 M |
| Operating Income | -$63.92 M | -$67.64 M | -$68.70 M | -$69.76 M | -$93.34 M | -$82.11 M |
| EBITDA | -$62.94 M | -$66.61 M | -$67.60 M | -$68.51 M | -$92.06 M | -$80.26 M |
| Interest Expense | -$2.98 M | -$3.02 M | -$3.00 M | -$2.83 M | -$2.78 M | -$2.79 M |
| Depreciation | $981.00 K | $1.03 M | $1.10 M | $1.25 M | $1.28 M | $1.85 M |
| Income Before Tax | -$64.05 M | -$67.81 M | -$69.42 M | -$64.65 M | -$88.61 M | -$78.76 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$64.05 M | -$67.81 M | -$69.42 M | -$64.65 M | -$88.61 M | -$78.76 M |
| Net Profit Margin | -598.74% | -503.86% | -477.3% | -487.95% | -821.62% | -584.51% |
Ocular Therapeutix, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $16.00 K | $17.00 K | $18.00 K | $22.00 K | $22.00 K | $22.00 K |
| Reserve & Surplus | -$955.14 M | -$1.02 B | -$1.09 B | -$1.16 B | -$1.25 B | -$1.32 B |
| Non-Current Liabilities | $102.06 M | $102.49 M | $103.36 M | $102.94 M | $103.27 M | $102.10 M |
| Current Liabilities | $37.93 M | $42.93 M | $49.29 M | $50.81 M | $47.68 M | $49.17 M |
| Total Liabilities | $139.99 M | $145.42 M | $152.65 M | $153.75 M | $150.96 M | $151.28 M |
| Fixed Assets | $10.78 M | $10.46 M | $16.95 M | $19.68 M | $18.43 M | $19.46 M |
| Current Assets | $387.69 M | $433.38 M | $386.98 M | $782.13 M | $706.00 M | $644.43 M |
| Total Assets | $405.92 M | $451.33 M | $410.88 M | $808.06 M | $732.53 M | $671.32 M |
Ocular Therapeutix, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$64.05 M | -$67.81 M | -$69.42 M | -$64.65 M | -$88.61 M | -$78.76 M |
| Operating Cash Flow | -$44.67 M | -$55.24 M | -$50.73 M | -$54.25 M | -$65.99 M | -$67.27 M |
| Investing Cash Flow | -$1.93 M | -$1.11 M | -$5.99 M | -$2.84 M | -$4.66 M | -$3.37 M |
| Financing Cash Flow | $4.18 M | $97.81 M | $10.36 M | $449.38 M | $294.00 K | $2.58 M |
| Change in Cash | -$42.42 M | $41.45 M | -$46.36 M | $392.29 M | -$70.36 M | -$68.06 M |
Ocular Therapeutix, Inc. Return Calculator
The Ocular Therapeutix, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$9,545
Invested Amount$10,000
Est. Returns$-455
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Popular Stocks
FAQs
What is the share price of Ocular Therapeutix, Inc. today?
Ocular Therapeutix, Inc. (OCUL) share price as of September 18, 2026 is $10.07. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ocular Therapeutix, Inc.?
Yes, Indian Investors can invest in the Ocular Therapeutix, Inc. (OCUL) Share by opening an international trading account with Angel One.
How can I purchase Ocular Therapeutix, Inc. shares in India?
Purchasing Ocular Therapeutix, Inc. (OCUL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ocular Therapeutix, Inc. (OCUL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ocular Therapeutix, Inc.?
Yes, you can purchase fractional shares of Ocular Therapeutix, Inc. (OCUL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ocular Therapeutix, Inc.?
The market capitalization of Ocular Therapeutix, Inc. on September 18, 2026, is $2.17 B.
In which sector Ocular Therapeutix, Inc. belongs?
Ocular Therapeutix, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ocular Therapeutix, Inc. stocks?
In order to invest in Ocular Therapeutix, Inc. (OCUL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
